Vara secures $8.9 million in funding and expands AI-powered breast cancer screening to India

Saturday, November 02, 2024

Vara, the innovative AI-powered platform for early detection of breast cancer, today announced the successful capital raise of $8.9 million (€8 million) that took place earlier this year. This capital increase welcomes three new lead investors: European family offices Smart Family Office (Austria) and FJH (Germany), as well as Berlin-based healthcare investor IBB Ventures.

Since its first deployment in 2019, Vara has achieved remarkable success in the German national breast cancer screening program. Today, almost 40% of breast cancer screenings in Germany are managed through Vara's AI platform, the only AI system deployed at scale in the program.

The program’s key achievements include:

  • More than 100,000 images per month are evaluated using Vara’s AI
  • Significantly higher cancer detection rates, including detection of 50% of tumors that radiologists would otherwise have missed
  • Fewer false-positive findings
  • Improved workflows for radiologists

Vara continues to expand into emerging healthcare markets, including India. The company partnered with NM Medical, a leading imaging services provider in Mumbai, Bangalore and Pune, in 2023. The goal of the collaboration is to raise the standard of breast cancer screening and early detection in India, with a focus on mammography as a cornerstone of women's health programs.

Jonas Muff, CEO of Vara, said: "This capital increase, which is particularly important in the current economic climate, not only represents a validation of our technology but also enables us to accelerate Vara's growth with a view to achieving a global impact. We are very pleased with the results we are already achieving together with our partners in the healthcare sector and we look forward to presenting further successes soon."

IBB Ventures participated in the financing round with its Impact Funds as lead investor. "Vara combines an AI-driven screening approach with proven medical evidence and commercialization in emerging markets and thus fits perfectly with the goals of our Impact Fund," says Ute Mercker, Investment Director at IBB Ventures. "Breast cancer is the most common cancer in women. By commercializing this innovative screening in India, we hope that Vara can increase survival rates and improve the quality of life of women."

In addition to the recent funding, Vara recently published the study “Strategies for integrating artificial intelligence into mammography screening programmes: a retrospective simulation analysis” in The Lancet Digital Health . The study evaluated the integration of artificial intelligence into mammography screening programmes using almost two million datasets from the UK, Sweden and Germany and found significant improvements across all key screening parameters, including improvements in cancer detection rates, reductions in recall rates and reductions in radiologist workload.

For more information about Vara, visit https://vara.ai .

About Vara
Vara is a healthcare technology company revolutionizing breast cancer screening with AI, founded in 2018 by Jonas Muff, CEO, and Stefan Bunk, CTO. Headquartered in Berlin, Germany, with offices in India, the company uses its AI-powered software to improve accuracy and efficiency in breast cancer detection, identifying 43% more cancers that radiologists might miss, while reducing their workload by up to 73%. Vara's approach has been shown to significantly outperform the average radiologist in numerous publications, including in the Lancet Digital Health. Vara is integrated into the nationwide breast cancer screening program in Germany and supports 40% of the country's screening centers, benefitting over 80,000 women every month. Now Vara is expanding its reach and making its life-saving technology accessible to underprivileged populations in India, with the goal of improving early detection and patient outcomes globally. Vara is backed by investors such as Merantix, EQT Foundation and VI Partners.

For more information, visit https://vara.ai/ .

About IBB Ventures
IBB Ventures (www.ibbventures.de) has been providing venture capital to innovative Berlin companies since 1997 and has established itself as the market leader in early-stage financing in Berlin. The funds are primarily used for the development and market launch of innovative products or services as well as share contact data for business concepts in the creative industries. In addition to our two VC funds for Berlin startups from the technology and creative industries with a total volume of 90 million euros, our Impact VC fund with a volume of 30 million euros has also been in the investment phase since 2022. All of our funds are supported by the Investitionsbank Berlin (IBB) and the European Regional Development Fund (ERDF) managed by the State of Berlin.

IBB Ventures has already invested in more than 260 Berlin creative and technology companies. In consortia with partners, the start-ups received more than 1.8 billion euros, of which IBB Ventures invested more than 275 million euros as lead, co-lead or co-investor. IBB Ventures is the umbrella brand for the VC activities of IBB Beteiligungsgesellschaft.

Contact Data
Media contact:
Erin Kim for Vara,
Ute Mercker for IBB Ventures,




Source: globenewswire.com